Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans

被引:21
|
作者
Elliott, AM
Kyosiimire, J
Quigley, MA
Nakiyingi, J
Watera, C
Brown, M
Joseph, S
French, N
Gilks, CF
Whitworth, JAG
机构
[1] Uganda Virus Res Inst, Entebbe, Uganda
[2] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[3] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[4] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[5] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1PG, England
关键词
tuberculosis; HIV; eosinophilia; Uganda;
D O I
10.1016/S0035-9203(03)90096-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
It has been suggested that type 1 immune responses protect against tuberculosis (TB), while type 2 responses, such as those induced by helminths, may suppress protective responses and increase susceptibility to TB. Factors associated with progression to active TB were investigated in a cohort of HIV-1-infected Ugandan adults, a group at high risk of TB. High rates of subsequent progression to active TB were associated with eosinophil counts greater than or equal to 0.4 x 10(9)/L at enrolment. Eosinophilia at enrolment was associated with male gender, low socio-economic status, high CD4+ T cell counts, and schistosomiasis, but adjusting for these factors did not explain the association of eosinophilia with progression to active TB (adjusted rate ratio = 2.76, P = 0.004). Eosinophilia is most likely to be indicative of a type 2 immune response induced by helminth infection in this Ugandan cohort, but the mechanism of the observed association between eosinophilia and risk of TB remains to be determined.
引用
收藏
页码:477 / 480
页数:4
相关论文
共 50 条
  • [21] Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
    Connor, RI
    Sheridan, KE
    Ceradini, D
    Choe, S
    Landau, NR
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04): : 621 - 628
  • [22] Expression of sarcolectin in sera of HIV-1-infected patients during progression of the disease
    Ilunga, AL
    Kaba, A
    Achour, A
    Zagury, JF
    Chany, C
    AIDS, 2000, 14 (14) : 2206 - 2207
  • [23] Disease progression in HIV-1-infected patients heterozygous for the sickle hemoglobin gene
    Sellier, Pierre
    Masson, Elisabeth
    Zini, Jean-M.
    Simoneau, Guy
    Magnier, Jean-D.
    Evans, John
    Bergmann, Jean-F.
    AIDS, 2009, 23 (17) : 2362 - 2364
  • [24] A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects
    Cecilia, D
    Kleeberger, C
    Muñoz, A
    Giorgi, JV
    Zolla-Pazner, S
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06): : 1365 - 1374
  • [25] Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants
    de Souza, RS
    Gómez-Marín, O
    Scott, GB
    Guasti, S
    O'Sullivan, MJ
    Oliveira, RH
    Mitchell, CD
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (02) : 154 - 161
  • [26] Inhibition of human immunodeficiency virus-1 (HIV-1) by β-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis
    Toossi, Z
    Mayanja-Kizza, H
    Baseke, J
    Peters, P
    Wu, M
    Abraha, A
    Aung, H
    Okwera, A
    Hirsch, C
    Arts, E
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 142 (02): : 327 - 332
  • [27] Intrusive HIV-1-infected cells
    Rudnicka, Dominika
    Schwartz, Olivier
    NATURE IMMUNOLOGY, 2009, 10 (09) : 933 - 934
  • [28] Intrusive HIV-1-infected cells
    Dominika Rudnicka
    Olivier Schwartz
    Nature Immunology, 2009, 10 : 933 - 934
  • [29] Lipodystrophy in HIV-1-infected patients
    Domingo, P
    Pérez, A
    Torres, OH
    Montiel, JA
    Vázquez, G
    LANCET, 1999, 354 (9181): : 868 - 868
  • [30] MICROSPORIDIOSIS IN HIV-1-INFECTED INDIVIDUALS
    BLANSHARD, C
    GAZZARD, BG
    LANCET, 1991, 337 (8755): : 1488 - 1489